Clinical & Operational Consulting

Full-service CRO with in-house research units in Sweden and the Netherlands. Psychedelic-specific evidence remains weaker than its general CNS and early-phase site-network capability.

Clinilabs Drug Development Corporation is the only global full-service contract research organisation (CRO) exclusively focused on central nervous system drug development, with over 25 years of experience managing Phase 1–3 trials across psychiatric, neurological, and substance-use disorders. It partnered with Cybin to conduct the first-in-human Phase 1/2a trial of CYB003, a deuterated psilocybin analog for major depressive disorder, obtaining DEA Schedule I licensing to support this psychedelic study.

US psychedelic drug-development consultancy providing clinical trial roadmaps, regulatory planning, and operational integration frameworks for emerging neuropsychiatry programs.

US-based cannabis and psychedelic consulting firm providing licensing, compliance, SOP, and operational support alongside strategic planning for psychedelic ventures.

Psychedelic integration and advisory practice offering preparation/integration support and explicit psychedelic business consulting and coaching for practitioners and service builders.

US-based consultancy supporting hospitals and clinics with psychedelic and ketamine service implementation, including strategic planning, staffing, protocol setup, and quality systems.

Psychedelic-focused consulting practice led by Scott Gagel, PA-C, offering clinically informed guidance, assessment, and consultation services for individuals exploring plant-medicine treatment pathways.

Target Health Inc. is a New York-based full-service contract research organization (CRO) and clinical trials software company. Known for its proprietary electronic data capture system and a 100% success rate on FDA market applications, it provides regulatory affairs, clinical research management, biostatistics, and paperless trial platform services to pharmaceutical and biotech sponsors.

An independent clinical research organization (CRO) founded in 1977 and headquartered in Rockville, Maryland, specializing in the design and management of clinical trials. Emmes has expertise across therapeutic areas including ophthalmology, neurology, and immunology, providing biostatistics, data management, and regulatory support for academic and government-sponsored trials.

Purpose-led healthcare consultancy focused on integrating psychedelic-assisted therapy into health systems, with explicit services across strategic planning, implementation, reimbursement, and go-to-market execution.

Global full-service CRO with a dedicated psychedelic center of excellence and stated experience supporting industry-sponsored psychedelic programs across psychiatric indications.